Project Grant HT94252310326
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$847K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Richardson, TX 75080, USA
Similar Awards
The University of Texas at Dallas (UTD) was awarded a $1,408,286 federal Project Grant by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Effectiveness of an Individualized Progressive Treatment for Expanding Sound Tolerance in Adults with Autism Spectrum Disorder: A Crossover Randomized Controlled Trial (RCT)", aims to conduct advanced biomedical research to develop innovative treatments for individuals with...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $451,000.00 to the University of Texas Southwestern Medical Center to conduct research on "DISSECTING BIOLOGICAL MECHANISMS UNDERLYING BEHAVIORAL HETEROGENEITY IN AUTISM" from April 1, 2024 to March 31, 2027. The research aims to advance scientific understanding of the biological basis for the variability in autism spectrum disorder symptoms and...
The federal Project Grant award of $2,790,262 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research aimed at examining neurobiological markers related to symptom improvement for individuals with traumatic brain injury-related tinnitus and comorbid post-traumatic stress disorder. The prime awardee, The University of Texas Health Science Center at San Antonio, will collaborate with the University of Illinois on this research, which...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
This federal Project Grant award, with a total funding amount of $1,971,504.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a crossover randomized controlled trial to evaluate the effectiveness of an individualized progressive treatment for expanding sound tolerance in adults with autism spectrum disorder. The research will be conducted by the University of Central Florida Board of Trustees over a...
This is a Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The $1,148,034.00 award, with a period of performance from September 15, 2024 to September 14, 2027, will fund the University of Illinois to develop objective biomarkers and novel treatment strategies for hidden hearing loss and hyperacusis. As a prominent research institution, the University of Illinois has extensive experience in conducting...
The U.S. Defense Health Agency has awarded a $357,989 Project Grant to the University of Cincinnati for the "MAGNETOPHOTOTHERMAL NANOPARTICLE DRUG DELIVERY FOR TREATING NOISE-INDUCED HEARING LOSS" research project under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective from September 1, 2025 to August 31, 2027, will support advanced biomedical research aimed at developing innovative magnetophotothermal nanoparticle-based drug delivery methods...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
The University of California, San Diego will research the mechanisms of heterogeneous neural expression of autism spectrum disorder under a three-year, $868,542 Project Grant from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Assistance Listing Number 12.420. This program supports biomedical research that transforms military and public health care through innovative solutions for battlefield...
The Project Grant award of $546,681 was granted by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "PROJECT IMPACT-AUTISM: INTERNET-BASED MODEL FOR PARAEDUCATORS TO AUGMENT COMPREHENSIVE TREATMENT FOR AUTISTIC LEARNERS" project at Temple University in Philadelphia, PA. The project aims to develop and evaluate an internet-based training model for paraeducators to enhance comprehensive treatment for...